Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Merck
Cantor Fitzgerald
Dow
Citi
Mallinckrodt
McKinsey
QuintilesIMS
Covington

Generated: April 19, 2018

DrugPatentWatch Database Preview

Galen Uk Company Profile

« Back to Dashboard

Summary for Galen Uk
International Patents:218
US Patents:18
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Galen Uk

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galen Uk ADASUVE loxapine POWDER;INHALATION 022549-001 Dec 21, 2012 RX Yes Yes 9,687,487 ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Galen Uk ADASUVE loxapine POWDER;INHALATION 022549-001 Dec 21, 2012 RX Yes Yes 7,078,020 ➤ Try a Free Trial Y ➤ Try a Free Trial
Galen Uk ADASUVE loxapine POWDER;INHALATION 022549-001 Dec 21, 2012 RX Yes Yes 8,387,612 ➤ Try a Free Trial Y ➤ Try a Free Trial
Galen Uk ADASUVE loxapine POWDER;INHALATION 022549-001 Dec 21, 2012 RX Yes Yes 8,991,387 ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for Galen Uk

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,070,766 Delivery of physiologically active compounds through an inhalation route ➤ Try a Free Trial
6,716,417 Delivery on nonsteroidal antiinflammatory drugs through an inhalation route ➤ Try a Free Trial
7,070,762 Delivery of analgesics through an inhalation route ➤ Try a Free Trial
6,737,042 Delivery of drug esters through an inhalation route ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for Galen Uk Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00609 Netherlands ➤ Try a Free Trial PRODUCT NAME: LOXAPINE; REGISTRATION NO/DATE: EU/1/13/823/001-002 20130220
3 Finland ➤ Try a Free Trial
2013 00046 Denmark ➤ Try a Free Trial PRODUCT NAME: LOXAPIN; REG. NO/DATE: EU/1/13/823/001-002 20130220
90040-2 Sweden ➤ Try a Free Trial PRODUCT NAME: LOXAPIN; REG. NO/DATE: EU/1/13/823/001 20130220
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Cantor Fitzgerald
US Department of Justice
AstraZeneca
QuintilesIMS
Farmers Insurance
Colorcon
Chubb
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.